PEOPLE - QLT makes appointment:
This article was originally published in Clinica
Executive Summary
Biopharmaceutical company QLT (Vancouver, Canada) has appointed of Robert Butchofsky as president and CEO, effective immediately. My Butchofsky has been acting CEO since September 2005, before which he was working on the launch of QLT's flagship drug, Visudyne. The company has also just appointed Boyd Clarke as its new chairman.
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.